Cibus Business Summary

Cibus, Inc. (CBUS) is a leading agricultural biotechnology firm that specializes in precision gene editing to enhance crop productivity and sustainability. The company generates revenue primarily through a royalty-based licensing model, partnering with seed companies to integrate its proprietary traits—such as herbicide tolerance (HT1, HT3), pod shatter reduction, and nitrogen use efficiency—into commercial varieties. Its business is centered on the Rapid Trait Development System (RTDS™) and the "Trait Machine™" platform, an automated end-to-end process for trait development in major crops including rice, canola, and soybean. As of early 2026, Cibus has streamlined its operations to prioritize near-term revenue opportunities in rice traits and partner-funded sustainable ingredients, such as bio-based fermentation fragrances. The company competes with diversified ag-tech giants and specialized biotech firms including Corteva, Bayer CropScience, Syngenta, and Benson Hill, distinguishing itself as a pure-play leader in non-transgenic (non-GMO) gene editing with a more efficient regulatory pathway. The company’s leadership is anchored by its founding team, which possesses extensive backgrounds in biotechnology and life sciences finance. Peter Beetham, Ph.D., a co-founder and pioneer in agricultural gene editing, serves as the President and Interim Chief Executive Officer, while co-founder Greg Gocal, Ph.D., serves as the Executive Vice President and Chief Scientific Officer. Rory Riggs, a co-founder and veteran biotech executive known for his roles at Sugen and Royalty Pharma, remains the Chairman of the Board and the company's largest shareholder. The executive team was further strengthened in late 2025 with the appointment of Cornelis (Carlo) Broos as Chief Financial Officer. Cibus is supported by a robust roster of institutional investors, including Fidelity Management & Research, Vanguard Group, and BlackRock, and its board includes notable industry figures such as Craig Wichner and Kimberly Box.